Advanced Medical Solutions Group (LON:AMS) Hits New 52-Week High – Here’s What Happened

Shares of Advanced Medical Solutions Group plc (LON:AMS) reached a new 52-week high during mid-day trading on Thursday. The stock traded as high as GBX 284.50 and last traded at GBX 283.01, with a volume of 357,783 shares changing hands. The stock had previously closed at GBX 283.

Advanced Medical Solutions Group Trading Up 0.0%

The stock has a 50-day moving average of GBX 281.86 and a two-hundred day moving average of GBX 247.46. The company has a market cap of £616.16 million, a P/E ratio of 171.53, a price-to-earnings-growth ratio of 5.00 and a beta of 0.75. The company has a debt-to-equity ratio of 33.60, a quick ratio of 4.58 and a current ratio of 2.94.

Advanced Medical Solutions Group (LON:AMS) last released its earnings results on Wednesday, September 16th. The company reported GBX 6.39 EPS for the quarter. Advanced Medical Solutions Group had a return on equity of 1.44% and a net margin of 1.58%. On average, equities research analysts predict that Advanced Medical Solutions Group plc will post 9.82 earnings per share for the current year.

Advanced Medical Solutions Group Company Profile

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®. AMS also supplies wound care dressings such as silver alginates, alginates and foams through its ActivHeal® brand as well as under white label.